You are here

AdvaMed COVID Testing Supply Registry

About the National COVID-19 Supply Registry

AdvaMed has been working closely with the White House, HHS, FDA, FEMA and other key government agencies to ensure the continued supply of diagnostics tests, as well as other vital medical equipment such as PPE and ventilators, in the fight against the COVID-19 pandemic.

To further assist state and federal governments in their pandemic responses, AdvaMed has created a comprehensive, national COVID-19 diagnostic supply registry which compiles information from diagnostic companies along with publicly available data on daily tests performed to create a centralized and standardized COVID-19 diagnostic supply registry.

AdvaMed’s registry aims to help streamline communications and data sharing between diagnostic companies and federal and state governments as well as standardize test supply reporting. It also facilitates collaboration with laboratories and other public health stakeholders to optimize access to all platforms of COVID-19 testing so that any potential shortages are identified and addressed quickly.

Learn More

Topline Data As of August 7, 2020

The registry’s latest dataset shows that since the beginning of the pandemic, roughly 110 million molecular COVID-19 tests have been manufactured and shipped nationwide, with shipments recently reaching about 1.1 million daily.

  • Since March, the 13 Registry participants have shipped about 110M cumulative COVID-19 tests​.
    • Abbott
    • BD 
    • BioMérieux 
    • Bio-Rad 
    • Beckman Coulter 
    • Cepheid 
    • Hologic 
    • Ortho Clinical Diagnostics 
    • QIAGEN 
    • Roche Diagnostics 
    • Sekisui Diagnostics 
    • Siemens Healthineers 
    • Thermo Fisher Scientific 
  • Across leading COVID diagnostic manufacturers, roughly 110 Million Molecular COVID-19 tests have been shipped since March, including ~80M commercial tests and ~30M extraction reagents
  • Manufacturers have increased Molecular test production from ~600,0001 shipments per day at the start of May to over 1.1 Million shipments per day1 by August 1st.
  • Per public sources, daily Molecular tests run continue to grow as well, increasing by ~30% over the past four weeks, reaching an all-time peak of over 860,000 tests per day2. In total, ~60 Million Molecular tests have been run in the U.S. since March.
  • High-quality Serology testing, authorized by FDA, is now available at scale with industry capacity to manufacture 100 million tests per month. Antigen testing is also beginning to ramp up.

1 Averaged over latest 4 weeks to account for fluctuations in buying cycle
2 Averaged over the week to account for fluctuations by day of the week

Weekly Reporting

The registry provides weekly state- and national-level updates on the number of molecular, antigen, and serology (antibody) tests shipped in the U.S.